{"href":"http://player.captivate.fm/services/oembed?url=http%3A%2F%2Fplayer.captivate.fm%2Fepisode%2F379f8605-7611-4b7b-a28a-055ad0cc50ce","version":"1.0","provider_name":"Captivate.FM","provider_url":"https://www.captivate.fm","width":600,"height":200,"type":"rich","html":"<iframe style=\"width: 100%; height: 200px;\" title=\"HER2-Positive Metastatic Breast Cancer with Professor Giuseppe Curigliano\" frameborder=\"0\" scrolling=\"no\" allow=\"clipboard-write\" seamless src=\"http://player.captivate.fm/episode/379f8605-7611-4b7b-a28a-055ad0cc50ce\"></iframe>","title":"HER2-Positive Metastatic Breast Cancer with Professor Giuseppe Curigliano","description":"\n        <p>Professor Giuseppe Curigliano from the European Institute of Oncology in Milan, Italy discusses recent therapeutic advances in HER2-positive metastatic breast cancer.</p>\n\n<p>CME information and select publications <a href=\"http://www.researchtopractice.com/OncologyTodayHER2PositivemBC22\" rel=\"nofollow\">here</a>.</p>\n      ","thumbnail_width":300,"thumbnail_height":300,"thumbnail_url":"https://artwork.captivate.fm/08ed27b5-1465-4dc9-ae80-1d60d349be22/cover.jpg"}